Actively Recruiting
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
Led by University of California, Los Angeles · Updated on 2026-03-04
50
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
CONDITIONS
Official Title
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prenatal care at UCLA Health
- Planning to deliver at UCLA Ronald Reagan or UCLA Santa Monica
- Confirmed gestational diabetes diagnosis based on 2-step approach
- Maternal age
You will not qualify if you...
- Pre-gestational diabetes (type 1 or type 2)
- Multifetal pregnancy
- Infection inside the amniotic sac by clinical criteria
- Excessive bleeding after delivery
- Admission to intensive care unit after delivery
- Known allergy to medical-grade adhesive
- Skin problems at the site where CGM will be applied
- Planned non-sonographic imaging (X-ray, MRI, or CT scan) after delivery during the study
- Use of metformin
- Use of steroids
- Use of terbutaline within 4 hours of delivery
- Cystic fibrosis
- Mature onset diabetes in the young (MODY)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
R
Rujuta Sathe
CONTACT
D
Dana Levin-Lopez, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here